Natural Killer Cells in Uterine Adenomyosis: Immunological Mechanisms and Therapeutic Perspectives
Journal of Immunology Research · 2026-01 · 2026 (1)
DOI: 10.1155/jimr/3833044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Immunology Research, online erschienen am 03.08.2026. Verfasst von Dilimulati Yalikun und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City 450052, Henan Province, China, zzu.edu…. Hauptthemen laut MEDLINE: Killer Cells, Natural, Adenomyosis. Die Arbeit nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Provincial-Ministrial Co-constructed Key Program of Henan Province, Young Talent Support Program of Natural Science Foundation of Henan Province.
Abstract (Originalsprache)
Uterine adenomyosis (AM), a common gynecological disorder, is characterized by the invasion of endometrial glands and stroma into the myometrium, resulting in chronic pelvic inflammation and severe pain. This condition not only adversely affects patients’ quality of life but also correlates with diminished fertility. Recent findings underscore the critical role of natural killer (NK) cells in the pathophysiology of AM. As a vital component of innate immunity, NK cells are responsible for identifying and eliminating abnormal cells, and functional alterations of NK cells may contribute to the progression of this disease. Although existing research has suggested preliminary associations between NK‐cell dysfunction and AM, the exact mechanistic pathways and their clinical implications are still not fully elucidated. This review comprehensively explores the involvement of NK cells in AM, emphasizing their functional adaptability within the immune microenvironment, interactions with cytokine networks, and potential for therapeutic targeting. Furthermore, we critically assess the translational hurdles and propose a strategic framework for implementing NK cell‐based immunomodulatory approaches in clinical practice.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou City 450052, Henan Province, China, zzu.edu.cn.
ORCID-Profile: Dilimulati Yalikun, Lulu Si, Hanlin Fu, Ruixia Guo
Förderung
- National Natural Science Foundation of China
- Provincial-Ministrial Co-constructed Key Program of Henan Province
- Young Talent Support Program of Natural Science Foundation of Henan Province
Zitieren
APA
Yalikun, D., Si, L., Fu, H., & Guo, R. (2026). Natural Killer Cells in Uterine Adenomyosis: Immunological Mechanisms and Therapeutic Perspectives. Journal of Immunology Research, 2026(1). https://doi.org/10.1155/jimr/3833044
Vancouver
Yalikun D, Si L, Fu H, Guo R. Natural Killer Cells in Uterine Adenomyosis: Immunological Mechanisms and Therapeutic Perspectives. Journal of Immunology Research. 2026;2026(1). doi:10.1155/jimr/3833044
BibTeX
@article{Yalikun2026,
author = {Yalikun, Dilimulati and Si, Lulu and Fu, Hanlin and Guo, Ruixia},
title = {Natural Killer Cells in Uterine Adenomyosis: Immunological Mechanisms and Therapeutic Perspectives},
journal = {Journal of Immunology Research},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/jimr/3833044}
}
EUVIMED